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A comprehensive study was performed on 25 bacterial clinical isolates originally identified as Corynebacte-
rium xerosis. Three reference strains of C. xerosis were also included in the study. On the basis of a variety of
phenotypic characteristics tested, all strains could be divided into two separate clusters: reference strains
ATCC 373 (the type strain of C. xerosis) and ATCC 7711 showed yellow-pigmented, dry, rough colonies,
fermented 5-keto-gluconate, exhibited strong leucine arylamidase and a-glucosidase activities, produced lac-
tate as the major end product of glucose metabolism, were susceptible to most of the 19 antimicrobial agents
tested, and showed an inhibition zone around disks containing the vibriocidal compound O/129. In contrast,
the remaining 26 strains including reference strain NCTC 7243 as well as all clinical isolates formed white-
grayish, dry, slightly rough colonies, did not ferment 5-keto-gluconate, exhibited only weak leucine arylamidase
and no a-glucosidase activity, produced large amounts of propionic acid as the end product of glucose
metabolism, and were resistant to most antimicrobial agents tested, including O/129. Chemotaxonomic (cel-
lular fatty acids, mycolic acids, and G1C content) and molecular genetic (16S rRNA gene sequence) investi-
gations revealed that the strains of the second cluster unambiguously belonged to the species C. amycolatum.
Our data suggest that most strains reported in the literature as C. xerosis are probably misidentified and
correspond to C. amycolatum.
Within the last few years numerous publications have fo-
cused on the disease associations of coryneform bacteria as
well as on the taxonomy of this heterogeneous group of bac-
teria. The reason for this is that clinical microbiologists and
clinicians have become more and more aware of the patho-
genic potential of coryneform bacteria, especially in immuno-
compromised patients. In recent years, one of the most fre-
quently reported coryneform bacteria causing infections in
humans has been Corynebacterium xerosis (2, 13, 16, 18, 19,
26–28). On the other hand, there are some reports of the
heterogeneity of what was generally thought to be C. xerosis
(6). The most recent and valuable study came from Coyle and
coworkers (7), who demonstrated multiple taxa within com-
mercially available reference strains of C. xerosis. In order to
clarify the identity of C. xerosis strains isolated from clinical
specimens, 25 strains originally identified as C. xerosis and
referred to two reference laboratories in Europe and North
America for identification were studied by applying phenotypic
as well as molecular genetic methods. Three reference strains
of C. xerosis were also included in the study for comparative
investigations. Some lipophilic strains available as C. xerosis
reference strains (7) were not included in the present investi-
gations since a recent study demonstrated that these strains
actually belong to some other already established taxa (17). C.
xerosis strains were identified according to the Hollis-Weaver
guide for the identification of gram-positive bacteria (14) and
not according to the criteria given in Bergey’s manual (6); i.e.,
C. xerosis strains produced acid from maltose. Most surpris-
ingly, all 25 clinical strains examined turned out to be C. amy-
colatum. Therefore, our observations cast doubt on the iden-
tities of most strains of so-called C. xerosis reported in the
literature.
MATERIALS AND METHODS
Strains, media, and growth conditions. The strains studied are listed in Table
1. The reference strains used for comparative investigations were obtained from
the American Type Culture Collection (ATCC; Rockville, Md.) and the National
Collection of Type Cultures (NCTC; London, United Kingdom). The other
strains were referred to the Department of Medical Microbiology (DMMZ),
University of Zürich, Zürich, Switzerland, and the Special Bacteriology Labora-
tory, Laboratory Centre for Disease Control (LCDC), Ottawa, Ontario, Canada,
between 1989 and 1995. For examination of the CAMP reaction, Staphylococcus
aureus ATCC 25923 was used. All strains were cultured on Columbia agar
(Difco, Detroit, Mich.) with 5% sheep blood (SBA) at 378C in a 5% CO2
atmosphere.
Biochemical tests. Preparation of the media used for biochemical character-
ization of the strains was done as described by Nash and Krenz (20). All bio-
chemical tests were carried out at 378C. Testing of the other biochemical char-
acteristics given in Table 2 has been outlined in detail previously (11, 12).
Hydrolysis of starch was tested on Mueller-Hinton agar plates after 48 h of
incubation by flooding the plates with a 1:5 dilution of Lugol’s iodine solution.
The commercial API (RAPID) Coryne system was used as recommended by the
manufacturer (API bioMérieux, Marcy l’Etoile, France); readings of the carbo-
hydrate fermentation reactions were done after 24 and 48 h of incubation. The
activities of leucine arylamidase and a-glucosidase were tested (apart from ex-
amination with the API Zym and the API Coryne systems) with Rosco tablets
(Rosco, Taastrup, Denmark) by preparing a bacterial suspension with turbidity
equivalent to that of a McFarland no. 3 standard and incubation for 18 h as
recommended by the manufacturer.
Antimicrobial susceptibility patterns. The susceptibilities of the 28 strains
included in the present study to 19 antimicrobial agents known to have activity
against coryneform bacteria were tested according to the guidelines for perfor-
mance and interpretation of the National Committee for Clinical Laboratory
Standards (21, 22). For interpretation of susceptibility to amoxicillin-clavulanic
acid, ampicillin, oxacillin, and penicillin, the categories for staphylococci were
used. MICs were tested by the agar dilution procedure (Mueller-Hinton agar
supplemented with 5% sheep blood). For susceptibility to the vibriocidal com-
pound O/129, disks with 150 mg of O/129 (Oxoid, Basingstoke, United Kingdom)
were placed on Mueller-Hinton agar supplemented with 5% sheep blood after
streaking the plates with a suspension with turbidity equivalent to that of a
McFarland no. 0.5 standard. Growth inhibition zones were observed after 24 h of
incubation at 378C.
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Gas-liquid chromatography. Determination of volatile and nonvolatile fatty
acids from the fermentation of glucose was performed as described previously
(11). For analysis of cellular fatty acids, cells were grown on Columbia agar base
(Oxoid) supplemented with 5% defibrinated sheep blood at 358C for 24 h in a 5%
CO2 incubator. Fatty acid derivatization and gas-liquid chromatography of the
cellular fatty acids were done as outlined before (4), except that we used MIDI
software, version 3.8.
Chemotaxonomic investigations. For the detection of the diamino acid of the
cell wall peptidoglycan and of the presence of mycolic acids, the methods out-
lined by Schaal (24) were applied. Cell wall components were separated by
thin-layer chromatography and were then visualized. The method for determi-
nation of the G1C contents of the bacterial DNAs was as given in an earlier
report (12).
16S rRNA gene sequence analysis. A large fragment of the 16S rRNA gene
was amplified from DNA by PCR with universal primers pA (positions 8 to 28;
Escherichia coli numbering) and pH (positions 1542 to 1522). The amplified
product was sequenced directly by using primers to conserved regions of the
rRNA. Sequencing was performed with a PRISM Dyedeoxy Terminator Cycle
Sequencing Kit (Applied Biosystems, Warrington, United Kingdom), and the
reaction products were electrophoresed with an Applied Biosystems model 373A
automatic DNA sequencer according to the manufacturer’s protocols (Applied
Biosystems). Sequences were compared by pairwise analysis (9).
RESULTS
Thirteen of the 25 clinical strains were isolated from blood
cultures or from intravascular catheters. Many other strains
came from infections which were anatomically closely related
to the skin. Two cases of urinary tract infections were noted,
but none of the clinical strains originated from a respiratory
tract specimen.
Macroscopic morphology separated all strains examined
into two groups (Table 1): all clinical strains grew as white-
grayish, dry, slightly rough colonies of 1 to 2 mm in diameter
after 48 h of incubation; these strains were referred to as C.
xerosis-like (later shown to be C. amycolatum) strains. The
other group (referred to as the C. xerosis group) contained the
TABLE 1. Strains included in the study
Strain group and no. Yr ofisolation Source
C. xerosis
ATCC 373 (type strain) 1924 Ear discharge
ATCC 7711 1940 NKa
C. amycolatum primarily
misidentified as C. xerosis
NCTC 7243 1947 Infant nose
DMMZ 103 1991 Blood culture
DMMZ 323 1992 Blood culture
DMMZ 1171 1994 Intravascular catheter
DMMZ 1303 1993 Deep wound, lower leg
DMMZ 1318 1994 Easy flow secretion
DMMZ 1373 NKb Urine
DMMZ 1422 1995 Retroauricular fistula
DMMZ 1423 1995 Fistula, upper leg
DMMZ 1480 1995 Deep wound, lower leg
DMMZ 1502 1995 Blood culture
DMMZ 1503 1995 Blood culture
DMMZ 1525 1995 Intravascular catheter
DMMZ 1528 1995 Intravascular catheter
DMMZ 1532 1995 Intravascular catheter
DMMZ 1563 1995 Abscess
DMMZ 1566 1995 Perianal abscess
DMMZ 1618 1995 Urine
DMMZ 1624 1995 Intravascular catheter
DMMZ 1668 1995 Intravascular catheter
DMMZ 1680 1995 Intravascular catheter
DMMZ 1788 1995 Blood culture
LCDC 89-0826 1989 Back wound
LCDC 91-0077 1991 Sternal bone fragments
LCDC 92-0042 1992 Aspirate from shoulder
LCDC 92-0043 1992 Blood culture
a NK, not known; the strain was originally from the University of Maryland
and was deposited in ATCC.
b NK, year not known.
TABLE 2. Biochemical characteristics of the strains studied
Reaction
Result for C.






Catalase 1 1 100
Motility 2 2 0
Nitrate reduction 1 2 96
Hydrolysis of
Urea 2 2 0
Esculin 2 2 0
Gelatin 2 2 0
Starch 1 (1)a 100
Casein 2 2 0
Tyrosine 2 2 0
Xanthine 2 2 0
CAMP reaction 2 2 0
Fermentation ofb:
Glucose 1 1 100
Maltose 1 1 100
Sucrose 1 1 100
Mannitol 2 2 0
Xylose 2 2 0
Ribose 1 1 92
Lactose 2 2 0
Glygogen 2 2 0
5-Keto-gluconate 1 1 0
Activity ofc:
Pyrazinamidased 1 1 100
Pyrrolidonyl arylamidased 2 2 0
Alkaline phosphatase 1 (w) 1 (w) 100 (s)
Esterase (C4) 1 (m) 1 (m) 100 (m)
Esterase lipase (C8) 1 (s) 1 (s) 100 (s)
Lipase (C14) 2 1 (w) 92 (w)
Leucine arylamidase 1 (s) 1 (s) 85 (w)
Valine arylamidase 2 2 0
Cystine arylamidase 1 (w) 1 (w) 100 (w)
Trypsin 2 2 0
Chymotrypsin 2 2 0
Acid phosphatase 1 (w) 1 (w) 100 (w)
Phosphoamidase 1 (w) 1 (w) 92 (w)
a-Galactosidase 2 2 0
b-Galactosidase 2 2 0
b-Glucuronidase 2 2 0
a-Glucosidase 1 (s) 1 (s) 0
b-Glucosidase 2 2 0
n-Acetyl-b-glucosaminidase 2 2 0
a-Mannosidase 2 2 0
a-Fucosidase 2 2 0
a Parentheses indicate weak activity only.
b All fermentation reactions except for that for 5-keto-gluconate were deter-
mined at 48 h of incubation; the reaction for 5-keto-gluconate was recorded at
120 h.
c As measured with the API Zym system. (w), approximately 5 nmol of sub-
strate hydrolyzed; (m), approximately 20 nmol of substrate hydrolyzed; (s), .40
nmol of substrate hydrolyzed.
d As measured with the API Coryne system.
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type strain of C. xerosis (ATCC 373) and reference strain
ATCC 7711 only. These two strains showed yellow-pigmented
(after 48 h of incubation on SBA at 378C), dry, and rough
colonies reminiscent of rapidly growing mycobacteria. Micro-
scopically, no differences were observed between the two
groups of strains since both showed typical club-shaped, non-
partially acid-fast, gram-positive organisms, as observed for
Corynebacterium spp. in general.
None of the key reactions usually applied in the routine
identification of coryneform bacteria (nitrate reduction, urea
hydrolysis, esculin hydrolysis, fermentation of glucose, mal-
tose, sucrose, mannitol, and xylose, and the CAMP test) were
found to differentiate the two groups of bacteria (Table 2). It
should be noted that reference strains ATCC 7711 and NCTC
7243 were unable to reduce nitrate (as also reported by others
[7]), whereas all other strains reduced nitrate. When applying
the API (RAPID) Coryne system, we observed that both
strains of the C. xerosis group exhibited strong a-glucosidase
activity which was not present in strains of the C. xerosis-like
group. This difference was confirmed by testing a-glucosidase
activity with the API Zym gallery as well as with Rosco tablets.
Furthermore, we found that in the 26 strains of the C. xerosis-
like cluster, leucine arylamidase activity was absent or only
weak, whereas the other two strains showed very strong activity
of this enzyme. In addition, the testing of all 28 strains included
in the present study with the API Zym system indicated stron-
ger activity of alkaline phosphatase in the strains of the C.
xerosis-like cluster than in the two other strains. The API 50
CH system did not provide further differential reactions be-
tween the two groups of organisms except that the two strains
of the C. xerosis group produced acid from 5-keto-gluconate,
which was not observed for any strain of the other group. All
C. xerosis-like strains produced large amounts of propionic
acid, whereas the two other strains produced lactate as their
major end product of the glucose metabolism.
Table 3 outlines the different API (RAPID) Coryne profiles
and identifications for all 28 strains tested after 24 and 48 h of
incubation. It should be noted that 24 and 25 of 26 C. xerosis-
like strains were identified with very good scores as C. xerosis
after 24 and 48 h of incubation, respectively.
The majority of the C. xerosis-like strains were multiresis-
tant, as revealed by the MICs at which 50% (MIC50s) and 90%
(MIC90s) of strains are inhibited (Table 4). Tetracycline, teico-
planin, and vancomycin were the only antimicrobial agents
whose MIC90s were below the breakpoints recommended by
the National Committee for Clinical Laboratory Standards
(22). In contrast, the two strains of the C. xerosis group were
susceptible to nearly all antimicrobial agents tested. Another
easy-to-perform test which clearly separated the two groups
was the resistance of all C. xerosis-like strains to the vibriocidal
compound O/129; both strains of the C. xerosis group showed
inhibition zones.
Cellular fatty acid analysis revealed qualitatively similar pat-
terns for both C. xerosis and C. xerosis-like strains (Table 5).
However, quantitative differences in the cellular fatty acid pat-
terns were noted, with significantly lower amounts of palmitic
acid but higher amounts of oleic acid in C. xerosis strains
compared with the amounts in the C. xerosis-like strains. In the
analyses of C. xerosis strains, not all resulting peaks could be
assigned to certain cellular fatty acids. These unidentifiable
peaks (at or near equivalent chain lengths 15.000, 16.8, and
17.000) represented cleaved mycolic acids. In contrast, no
peaks suggestive of cleaved mycolic acids were detected in the
C. xerosis-like strains.
All 28 strains studied containedmeso-diaminopimelic acid in
their peptidoglycan. In both C. xerosis strains, mycolic acids
could be detected, but in the C. xerosis-like strains, no mycolic
acids were found, even after repeated attempts. The only spe-
cies within the genus Corynebacterium not containing mycolic
acids is C. amycolatum (5, 6, 23). Determination of the G1C
contents of the two C. xerosis strains revealed values of 66 to 69
mol%; in contrast, the C. xerosis-like strains possessed signifi-
cantly lower amounts of G1C (55 to 60 mol%).
To further investigate the possible affinity between C. xero-
sis-like strains and C. amycolatum, phylogenetic analyses were
performed. A large fragment of the 16S rRNA genes of five
representative clinical isolates (strains DMMZ 323, DMMZ
1171, DMMZ 1303, DMMZ 1318, and DMMZ 1422) and
strain NCTC 7243 was amplified by PCR and sequenced. Ap-
proximately 1,400 bases were determined for each strain, and
pairwise analyses showed the six strains to be highly related to
each other and to the type strain of C. amycolatum (strain
NCFB 2768 [5]). Considerably lower sequence relatedness
(,98%) was shared with C. xerosis ATCC 373, to which the
16S rRNA gene sequence of reference strain ATCC 7711 was
identical. These findings demonstrate that the C. xerosis-like
group of strains do not correspond to C. xerosis but are repre-
sentatives of the species C. amycolatum.
DISCUSSION
Phenotypic, chemotaxonomic, and molecular genetic inves-
tigations revealed that none of the 25 clinical isolates studied

















C. striatum 23.3 0.35
3110325
(ATCC 373)





C. minutissimum 97.1 0.92 Good
3100105 (1) C. striatum 97.1 1.00 Good
3100125 (14) C. xerosis 99.7 0.95 Very good
3100325 (10) C. xerosis 99.6 1.00 Very good
48 h
C. xerosis (n 5 2)
2110325
(ATCC 7711)
C. minutissimum 53.2 0.50 Doubtful
C. xerosis 46.7 0.49
3110325
(ATCC 373)





C. minutissimum 97.9 1.00 Good
3100125 (2) C. xerosis 99.7 0.95 Very good
3100325 (23) C. xerosis 99.6 1.00 Very good
a Identification percentages of less than 3.0 were not reported.
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belonged to the species represented by the C. xerosis type strain
(ATCC 373). The reference strain ATCC 7711 is a true C.
xerosis strain, whereas the reference strain NCTC 7243 belongs
to C. amycolatum.
For the routine clinical laboratory, we recommend use of the
following criteria for differentiating between C. xerosis and C.
amycolatum strains: dry, rough colonies of fermentative
coryneform bacteria with yellowish pigment should raise the
suspicion of C. xerosis, whereas C. amycolatum exhibits dry
colonies which are never pigmented; susceptibility to O/129
differentiates the susceptible C. xerosis strains from the resis-
tant C. amycolatum strains; the activity of a-glucosidase also
provides a clear-cut distinction between C. xerosis (positive
reaction) and C. amycolatum (negative reaction) strains. Fur-
ther means of differentiation include the detection of major
amounts of propionic acid (C. amycolatum) rather than lactic
acid (C. xerosis) as an end product of glucose fermentation and
assays for the presence (C. xerosis) or absence (C. amycolatum)
of mycolic acids. Different G1C contents had been reported
before for ‘‘C. xerosis’’ strains (6), which can now be explained
by the fact that C. amycolatum strains (55 to 60 mol% G1C)
have a significantly lower G1C content than authentic C. xe-
rosis strains (66 to 69 mol%). Subtle quantitative (C16:0 and
C18:1v9cis) and qualitative (presence [C. xerosis] or absence [C.
amycolatum] of poorly cleaved mycolic acids) differences may
also assist in the differentiation of these taxa.
In our experience, C. xerosis is extremely rarely found in
clinical specimens, whereas C. amycolatum is probably the
most frequently encountered nonlipophilic Corynebacterium
species in clinical specimens. Because C. amycolatum is vari-
able for many biochemical reactions such as nitrate reduction,
urea hydrolysis, and fermentation of maltose and sucrose (3,
5), it seems most likely that many more C. amycolatum strains
are misidentified as C. striatum or C. minutissimum, as outlined
by Barreau et al. (3). We therefore emphasize that every strain
of fermenting coryneform bacteria with dry colonies should
raise the suspicion of C. amycolatum.
The misidentification of C. amycolatum as C. xerosis is al-
lowed by the Hollis-Weaver charts (14) (which could not pos-
sibly contain C. amycolatum because this species was proposed
later by Collins and coworkers [5]) since none of the 33 bio-
chemical features given in the tables separates C. amycolatum
from C. xerosis. The commercial API (RAPID) Coryne system
may also misidentify C. amycolatum strains as C. xerosis (Table
3); its database states that only 4% of all C. xerosis strains are
a-glucosidase positive (1). Therefore, it seems likely that the
database for C. xerosis was constructed with C. amycolatum
strains. a-Glucosidase activity is a good marker for C. xerosis
strains because only a few other Corynebacterium species
pathogenic for humans (C. diphtheriae, C. ulcerans, C. pseudo-
tuberculosis, and C. glucuronolyticum) exhibit activity of this
enzyme, and all of these strains can be readily distinguished
from C. xerosis (1, 6, 10). It is important to note that nitrate
reduction in authentic C. xerosis strains is variable, which is in
contrast to the data given both in the Hollis-Weaver charts (14)
as well as in the API (RAPID) Coryne database (1).
TABLE 5. Cellular fatty acid patterns of the strains studied
Component
% Cellular fatty acids (mean 6 SD [range])a
C. xerosis (n 5 2) C. amycolatum
(n 5 24)bATCC 373 ATCC 7711
C14:0 1 6 1 (0–1)
C16:1v9cis 2 1 2 6 1 (1–2)
C16:0 12 16 26 6 2 (24–31)
C17:0 3 6 2 (1–7)
Feature 6c 1 2 2 6 1 (2–3)
C18:1v9cis 54 46 36 6 3 (33–39)
Feature 7d 2 2 1 6 1 (0–2)
C18:0 16 27 29 6 3 (24–35)
a Amounts of less than 1% were not reported.
b Two of the 26 C. amycolatum strains were not included in this analysis.
c Feature 6 contains C18:2v6cis, C18:2v9cis, and C18:0anteiso.
d Feature 7 contains C18:1v7cis, C18:1v9trans, and C18:1v12trans.
TABLE 4. Antimicrobial susceptibility patterns of the strains studieda
Substance
MIC (mg/ml)
C. xerosis (n 5 2) C. amycolatum (n 5 26)
ATCC 373 ATCC 7711 Range 50% 90%
Amoxicillin-clavulanic acid #0.03 0.06 0.13–.64 1 64
Ampicillin 0.125 0.125 0.25–.64 2 .64
Ceftriaxone 0.25 0.125 0.5–.64 1 .64
Cefuroxime 0.06 0.06 0.25–.64 0.5 .64
Cephalothin 0.06 0.06 0.13–.64 1 .64
Chloramphenicol 8 8 16–32 32 32
Ciprofloxacin 2 2 4–.64 .64 .64
Clindamycin 2 4 0.25–.64 .64 .64
Erythromycin 0.125 8 #0.03–.64 .64 .64
Gentamicin #0.03 0.125 4–.64 16 32
Imipenem #0.03 #0.03 #0.03–.64 0.5 .64
Oxacillin 1 0.5 2–.64 16 .64
Penicillin 0.06 0.06 0.25–.64 2 .64
Rifampin #0.03 #0.03 #0.03–.64 .64 .64
Sparfloxacin 2 4 #0.03–32 32 32
Teicoplanin 0.125 0.5 0.13–0.5 0.5 0.5
Tetracycline 1 2 0.5–32 1 2
Trimethoprim-sulfamethoxazole 16 16 .64 .64 .64
Vancomycin 0.25 0.25 0.13–0.5 0.25 0.25
a Susceptibility to O/129 was determined by the disk diffusion method (see text). The C. xerosis strains were susceptible to O/129 (inhibition zone, 12 to 28 mm), and
the C. amycolatum strains were resistant.
VOL. 34, 1996 C. XEROSIS REPRESENTING MISIDENTIFIED C. AMYCOLATUM 1127
Coyle et al. (7) assigned 3 of the 10 ‘‘C. xerosis’’ reference
strains examined in their study to the species C. striatum, 4 of
the 10 strains belonged to some lipophilic Corynebacterium
species (7, 17), and this report demonstrated that strain NCTC
7243 is C. amycolatum. In contrast to our results, Coyle et al.
(7) assigned strains ATCC 373 and ATCC 7711 to different
hybridization groups, i.e., separate species. However, our data
indicating 100% homology within the 16S rRNA genes of both
strains demonstrate that they most likely belong to the same
species. The reason for this discrepancy is unclear. Profiles of
whole-cell protein electrophoresis as well as the mycolic acid
patterns were almost identical for strains ATCC 373 and
ATCC 7711, thereby reinforcing the close relation between the
two strains (8, 15).
Like C. jeikeium and C. urealyticum, many C. amycolatum
strains are resistant to multiple antibiotics. The molecular basis
for this feature of C. amycolatum strains is not known at
present. Nearly all multiresistant C. amycolatum strains re-
mained susceptible to tetracycline, an observation that was also
reported by Soriano et al. (25) for their so-called C. xerosis
strains.
We conclude that the majority of strains designated ‘‘C.
xerosis’’ in the literature may have been, in fact, misidentified
C. amycolatum strains. True C. xerosis strains are, in our expe-
rience, extremely rarely encountered in clinical specimens.
Therefore, for future publications on C. xerosis, performance
of the minimal set of tests outlined above seems to be neces-
sary to ensure the identity of the tested strains as authentic C.
xerosis strains.
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Hochschulverein Zürich. G.F. acknowledges support by a grant from
the Sassella-Stiftung (Zürich, Switzerland).
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